For medtech regulatory affairs (RA) professionals, one crucial aspect of their job is managing product renewals to maintain regulatory compliance in various regions around the globe. With hundreds or even thousands of registrations across different markets, each with its own renewal cycle ranging from three, five, or even 10 years from their approved date, the task of proactively managing renewals can be daunting and error-prone.
Traditional renewal management practices often rely on siloed data stored in various systems and spreadsheets across the organization. In a recent regulatory benchmark study, 69% of participants reported that they had no alert system in place for license expirations or the alerts weren’t specific to individual renewals. This fragmented approach makes it difficult to obtain a comprehensive overview of renewal dates, increases the risk of missed deadlines, and results in potential product delays. Moreover, notifications regarding upcoming renewals often arrive late, leaving RA teams scrambling to catch up.
This disjointed process may also overlook the input of sales teams. Sales people have valuable insights into product demand and market trends, which can inform decisions on whether to renew or discontinue certain products. Without this collaboration, RA teams may invest time and resources on renewals for products that are no longer aligned with market demand.
Proactive renewal management offers a strategic approach to managing product renewals, bringing efficiency and cost savings to the RA process. By implementing proactive measures, companies can reap several benefits:
When adopting a proactive approach to renewal management consider these few key steps:
To learn more about how a single source of truth can streamline renewal management and the entire end-to-end regulatory lifecycle, read this feature brief for Veeva Registrations.